{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:53:28Z","timestamp":1789685608744,"version":"4.0.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007194","name":"Wenzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007194","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jgisurgery.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gastrointestinal Surgery"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.gassur.2024.01.025","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T17:47:27Z","timestamp":1706809647000},"page":"375-380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The correlation of sarcopenia and adverse events of imatinib therapy postoperatively in gastrointestinal stromal tumor through computed tomography quantitative body composition"],"prefix":"10.1016","volume":"28","author":[{"given":"Xinyi","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanyu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.gassur.2024.01.025_bib1","first-page":"889","article-title":"Diagnosis and management of gastrointestinal stromal tumors: an up-to-date literature review","volume":"13","author":"El-Menyar","year":"2017","journal-title":"J Cancer Res Ther"},{"issue":"2","key":"10.1016\/j.gassur.2024.01.025_bib2","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3390\/diagnostics11020194","article-title":"Update on Molecular Genetics of gastrointestinal stromal tumors","volume":"11","author":"Br\u010di\u0107","year":"2021","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"10.1016\/j.gassur.2024.01.025_bib3","article-title":"Gastrointestinal stromal tumours","volume":"7","author":"Blay","year":"2021","journal-title":"Nat Rev Dis Prim"},{"issue":"08","key":"10.1016\/j.gassur.2024.01.025_bib4","first-page":"834","article-title":"c-Kit and PDGFRA gene mutation in gastrointestinal stromal tumor and their associations with clinicopathologyical features, immunohistochemical expression and prognosis","volume":"34","author":"Yamamoto","year":"2018","journal-title":"J Clin Exp Pathol"},{"issue":"20","key":"10.1016\/j.gassur.2024.01.025_bib5","first-page":"3707","article-title":"Clinicaopathological features and prognostic factors of wild-type Gastrointestinal stromal tumors","volume":"31","author":"Qin","year":"2022","journal-title":"Henan Med Res"},{"issue":"2","key":"10.1016\/j.gassur.2024.01.025_bib6","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3390\/ijms22020493","article-title":"Gastrointestinal stromal tumors (GISTs): novel therapeutic strategies with immunotherapy and small molecules","volume":"22","author":"Vallilas","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"13","key":"10.1016\/j.gassur.2024.01.025_bib7","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.3390\/cancers13133158","article-title":"Recent progress and challenges in the diagnosis and treatment of gastrointestinal stromal tumors","volume":"13","author":"Nishida","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.gassur.2024.01.025_bib8","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/s41571-022-00606-4","article-title":"New treatment strategies for advanced-stage gastrointestinal stromal tumours","volume":"19","author":"Klug","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.gassur.2024.01.025_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-91439-8_1","article-title":"Imatinib mesylate","volume":"212","author":"Waller","year":"2018","journal-title":"Recent Results Cancer Res"},{"issue":"1","key":"10.1016\/j.gassur.2024.01.025_bib10","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-020-01026-6","article-title":"The management of metastatic GIST: current standard and investigational therapeutics","volume":"14","author":"Kelly","year":"2021","journal-title":"J Hematol Oncol"},{"issue":"14","key":"10.1016\/j.gassur.2024.01.025_bib11","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.3390\/cancers13143525","article-title":"Immunotherapy strategies for gastrointestinal stromal tumor","volume":"13","author":"Arshad","year":"2021","journal-title":"Cancers"},{"issue":"9669","key":"10.1016\/j.gassur.2024.01.025_bib12","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0140-6736(09)60500-6","article-title":"Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial","volume":"373","author":"Dematteo","year":"2009","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.gassur.2024.01.025_bib13","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jama.2012.347","article-title":"One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial","volume":"307","author":"Joensuu","year":"2012","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.gassur.2024.01.025_bib14","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1159\/000502749","article-title":"Safety of imatinib mesylate in a multicenter expanded access program in adult patients with gastrointestinal stromal tumors in the adjuvant setting","volume":"42","author":"Reichardt","year":"2019","journal-title":"Oncol Res Treat"},{"issue":"1","key":"10.1016\/j.gassur.2024.01.025_bib15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"issue":"2","key":"10.1016\/j.gassur.2024.01.025_bib16","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1245\/s10434-015-4887-3","article-title":"Sarcopenia adversely impacts postoperative clinical outcomes following gastrectomy in patients with gastric cancer: A prospective study","volume":"23","author":"Wang","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.gassur.2024.01.025_bib17","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejso.2016.09.006","article-title":"Sarcopenia in overweight and obese patients is a predictive factor for postoperative complication in gastric cancer: A prospective study","volume":"43","author":"Lou","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.gassur.2024.01.025_bib18","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/jcsm.12274","article-title":"Preoperative sarcopenia and post-operative accelerated muscle loss negatively impact survival after resection of pancreatic cancer","volume":"9","author":"Hyung","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"10","key":"10.1016\/j.gassur.2024.01.025_bib19","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1007\/s00268-019-05054-3","article-title":"Change in skeletal muscle following resection of Stage I-III colorectal cancer is predictive of poor survival: A cohort study","volume":"43","author":"Hopkins","year":"2019","journal-title":"World J Surg"},{"issue":"3","key":"10.1016\/j.gassur.2024.01.025_bib20","article-title":"Prognostic and predictive implications of sarcopenia in Western patients undergoing gastric resections for carcinoma of the stomach","volume":"120","author":"Marek","year":"2019","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.gassur.2024.01.025_bib21","article-title":"Preoperative sarcopenia and systemic immune-inflammation index can predict response to intravesical Bacillus Calmette-Guerin instillation in patients with non-muscle invasive bladder cancer","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.gassur.2024.01.025_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2022.100422","article-title":"Impact of adjuvant imatinib on bone and muscle density in patients with resected gastrointestinal stromal tumors","volume":"34","author":"Fulgenzi","year":"2022","journal-title":"J Bone Oncol"},{"issue":"1","key":"10.1016\/j.gassur.2024.01.025_bib23","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-022-02479-4","article-title":"Effect of skeletal muscle loss during neoadjuvant imatinib therapy on clinical outcomes in patients with locally advanced GIST","volume":"22","author":"Ding","year":"2022","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"10.1016\/j.gassur.2024.01.025_bib24","doi-asserted-by":"crossref","first-page":"281","DOI":"10.21147\/j.issn.1000-9604.2017.04.01","article-title":"Chinese consensus guidelines for diagnosis and management of gastrointestinal stromal tumor","volume":"29","author":"Li","year":"2017","journal-title":"Chin J Cancer Res"},{"issue":"16","key":"10.1016\/j.gassur.2024.01.025_bib25","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1158\/0008-5472.CAN-18-0125","article-title":"LIFEx: a freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity","volume":"78","author":"Nioche","year":"2018","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.gassur.2024.01.025_bib26","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.gassur.2024.01.025_bib27","unstructured":"SPSS 26.0: IBM Corp. Released 2019. IBM SPSS Statistics for Windows, Version 26.0. Armonk, NY: IBM Corp."},{"issue":"7","key":"10.1016\/j.gassur.2024.01.025_bib28","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1056\/NEJMoa020461","article-title":"Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors","volume":"347","author":"Demetri","year":"2002","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.gassur.2024.01.025_bib29","article-title":"Sarcopenia in daily practice: assessment and management","volume":"16","author":"Charlotte","year":"2016","journal-title":"BMC Geriatr"},{"issue":"1","key":"10.1016\/j.gassur.2024.01.025_bib30","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/ageing\/afz046","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"issue":"1","key":"10.1016\/j.gassur.2024.01.025_bib31","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-022-09278-w","article-title":"Sarcopenia as a novel prognostic factor in the patients of primary localized gastrointestinal stromal tumor","volume":"22","author":"Song","year":"2022","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.gassur.2024.01.025_bib32","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1158\/1535-7163.MCT-18-0498","article-title":"Association of imatinib plasma concentration and single-nucleotide polymorphisms with adverse drug reactions in patients with gastrointestinal stromal tumors","volume":"17","author":"Zhang","year":"2018","journal-title":"Mol Cancer Ther"},{"issue":"5","key":"10.1016\/j.gassur.2024.01.025_bib33","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/s10147-023-02325-x","article-title":"Plasma trough concentration of imatinib and its effect on therapeutic efficacy and adverse events in Japanese patients with GIST","volume":"28","author":"Teranishi","year":"2023","journal-title":"Int J Clin Oncol"},{"issue":"Suppl 9","key":"10.1016\/j.gassur.2024.01.025_bib34","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1002\/cncr.32751","article-title":"Correlations between imatinib plasma trough concentration and adverse reactions in Chinese patients with gastrointestinal stromal tumors","volume":"126","author":"Xia","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.gassur.2024.01.025_bib35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejca.2015.12.029","article-title":"Relationship between imatinib trough concentration and outcomes in the treatment of advanced gastrointestinal stromal tumours in a real-life setting","volume":"57","author":"Bouchet","year":"2016","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.gassur.2024.01.025_bib36","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s11739-020-02589-5","article-title":"Prognostic value of skeletal muscle mass during tyrosine kinase inhibitor (TKI) therapy in cancer patients: a systematic review and meta-analysis","volume":"16","author":"Rinninella","year":"2021","journal-title":"Intern Emerg Med"},{"issue":"11","key":"10.1016\/j.gassur.2024.01.025_bib37","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1093\/annonc\/mds198","article-title":"Adjuvant therapy in primary GIST: state-of-the-art","volume":"23","author":"Reichardt","year":"2012","journal-title":"Ann Oncol"},{"issue":"13","key":"10.1016\/j.gassur.2024.01.025_bib38","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003164","article-title":"Sarcopenia is an independent predictor of severe postoperative complications and long-term survival after radical gastrectomy for gastric cancer: analysis from a large-scale cohort","volume":"95","author":"Zhuang","year":"2016","journal-title":"Med (Baltim)"},{"issue":"4","key":"10.1016\/j.gassur.2024.01.025_bib39","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/jcsm.12047","article-title":"Reversible sarcopenia in patients with gastrointestinal stromal tumor treated with imatinib","volume":"6","author":"Moryoussef","year":"2015","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"12","key":"10.1016\/j.gassur.2024.01.025_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41577-023-00877-7","article-title":"Protein kinases: drug targets for immunological disorders","volume":"23","author":"Castelo-Soccio","year":"2023","journal-title":"Nat Rev Immunol"},{"issue":"23","key":"10.1016\/j.gassur.2024.01.025_bib41","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","article-title":"Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia","volume":"355","author":"Druker","year":"2006","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.gassur.2024.01.025_bib42","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1182\/blood.V99.10.3530","article-title":"Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study","volume":"99","author":"Sawyers","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.gassur.2024.01.025_bib43","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jhep.2015.02.031","article-title":"Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma","volume":"63","author":"Fujiwara","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.gassur.2024.01.025_bib44","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijsu.2016.04.049","article-title":"Adverse impact of low skeletal muscle index on the prognosis of hepatocellular carcinoma after hepatic resection","volume":"30","author":"Yabusaki","year":"2016","journal-title":"Int J Surg"},{"key":"10.1016\/j.gassur.2024.01.025_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.881121","article-title":"Body mass index combined with possible sarcopenia status is better than BMI or possible sarcopenia status alone for predicting all-cause mortality among Asian community-dwelling older adults","volume":"9","author":"Chalermsri","year":"2022","journal-title":"Front Nutr"},{"issue":"01","key":"10.1016\/j.gassur.2024.01.025_bib46","first-page":"71","article-title":"Progress of sarcopenia: diagnosis, treatment and research progress","volume":"20","author":"Zhen","year":"2023","journal-title":"Biol Orthop Mater Clin Res"}],"container-title":["Journal of Gastrointestinal Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X24001318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X24001318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T12:09:03Z","timestamp":1733227743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091255X24001318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1091255X24001318"],"URL":"https:\/\/doi.org\/10.1016\/j.gassur.2024.01.025","relation":{},"ISSN":["1091-255X"],"issn-type":[{"value":"1091-255X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The correlation of sarcopenia and adverse events of imatinib therapy postoperatively in gastrointestinal stromal tumor through computed tomography quantitative body composition","name":"articletitle","label":"Article Title"},{"value":"Journal of Gastrointestinal Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gassur.2024.01.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Society for Surgery of the Alimentary Tract. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}